dispensing Dexcom G7 CGM:

what you need to know

dexcom g7

THE CONTINUOUS GLUCOSE MONITORING (CGM)
SYSTEM TRANSFORMING DIABETES MANAGEMENT

With Dexcom G7, there is no separate transmitter needed. Each box contains 1 sensor that will last for 10 days, so each monthly prescription should include 3 boxes. If patients opt to use a compatible smart device, only dispense the sensor boxes. If patients do not have a smart device, the Dexcom G7 receiver will be required to access their data.

The Dexcom G7 sensor and receiver are available through major retailers, including Cardinal Health, McKesson, Cencora, Dakota Drug, and Smith Drug.

 

DOWNLOAD THE PHARMACY TOOLKIT
FOR MORE INFORMATION

DOWNLOAD NOW

 

dexcom g7

dexcom g7 receiver

PRODUCT COMPONENTS

DEXCOM G7 SENSOR

DEXCOM G7 RECEIVER

PRODUCT NRC 08627-0077-01 08627-0078-01
FILL 3 boxes (1 sensor per box) 1
REFILLS 30 days

1 year

*To view a list of compatible devices, visit dexcom.com/compatibility. Receiver required for Medicare beneficiaries.

DEXCOM G7 IS BUILT FOR POWERFULLY

SIMPLE, CONFIDENT DIABETES MANAGEMENT

Dexcom G7 is indicated for use with children ages 2 and up,

and it can be used with no limitations during pregnancy.

 

the most accurate CGM1

checkmark circle  INDUSTRY-LEADING CGM THAT IMPROVES OUTCOMES2-7

  • >1% A1C reduction*,1,7
  • More time in range2-6
  • Lower hyper- and hypoglycemia2-6

 Dexcom G7 Continuous Glucose Monitor for type-1 and type-2 diabetes patients

Smart device sold separately.* 

 

the simple CGM

FOR EFFORTLESS DIABETES MANAGEMENT THAT LEADS TO BETTER ADHERENCE†,7

 

Image
60%
Image
2x
Image
all in 1

 

the most covered CGM brand10

AFFORDABLE CARE FOR PATIENTS WITH DIABETES TYPE 1 OR 2, DURING PREGNANCY, OR THOSE ON MEDICARE‡,8

 

3x graphic

Pay $0 than FreeStyle Libre patients10

only 1 prescription needed

Your patients can start quickly with the Simple Start Program at the pharmacy

 
IF YOUR PATIENT NEEDS HELP WITH COVERAGE,
THE DEXCOM SAVINGS CENTER CAN HELP
 

LEARN MORE

 

*Results obtained in a real-world study after 12 weeks of use (N=248). Based on 30 days of use. Must meet eligibility requirements. Under Medicare’s DME fee schedule, reimbursement for CGMs, using CPT codes K0554 and K0553, is the same, regardless of CGM brand. Regulation at 42 CFR 410.152(b), stipulates that coinsurance for items of durable medical equipment is 20% of the allowed amount.

the all-in-one app experience

g7 overview video

Dexcom G7 is the latest in CGM technology, offering an all-in-one app experience made to help empower patients to act before a potentially dangerous hypo- or hyperglycemia event.

checkmark circle  Features a simplified design and real-time and retrospective insights

phone icon  Patients can view their glucose readings directly on a compatible smart device or a Dexcom G7 receiver

X icon  No scanning and no fingersticks required

bell icon  Flexible alerts including a hyperglycemia alert and a new Urgent Low Soon alert

dexcom follow app icon  Patients can use the separate Follow app* to share glucose information with up to 10 followers

*Followers must have compatible smart devices to use the Dexcom Follow app.

getting patients started with Dexcom G7 is easy

dexcom g7 video

Applying Dexcom G7 is simple

  • Select sensor site
  • Insert the sensor using the applicator
  • Pair the receiver or compatible smart device
  • Dexcom G7 features a fast 30-minute warmup once applied to the body
  • Keep smart device or receiver nearby during warmup


WATCH THE FULL VIDEO

 

pharmacy toolkit

 

Dexcom G7 pharmacy toolkit

The toolkit is designed to help answer any questions you or your patients may have about Dexcom G7.

DOWNLOAD THE PHARMACY TOOLKIT FOR MORE INFORMATION

 

DOWNLOAD NOW

are your patients connected to a pump?

We recommend new users on automated insulin delivery (AID) systems to explore the benefits of Dexcom G6 and for existing users on AID systems to stay on Dexcom G6 until Dexcom G7 is compatible with your pump.

 

EXPLORE DEXCOM G6

1 Dexcom, data on file, 2022. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 7 Seagrove Partners Patient Perspectives, 2022. 8 Dexcom G7 CGM System User Guide. 9 FreeStyle Libre 3 Quick Start Guide. Abbott Diabetes Care Inc.; 2022. 10 Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022.

The circular shape of the sensor housing, FreeStyle Libre, and related brand marks are marks of Abbott.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Contact Reason

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)
As listed on Provider’s medical license (no MD, Jr., Sr.)
Please use the Provider's NPI
Please provide the facility address
Is your patient on a connected pump device?

 

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.